Tape Stripping — Searching for Minimally Invasive Biomarkers in Atopic Dermatitis
Keywords:
Atopic dermatitis, biomarkers, precise treatment, tape-stripsAbstract
Atopic dermatitis (AD) is nowadays entering a new era of more targeted treatments. However, to make personalized medicine, which we are currently striving for, a reality, a reliable set of validated biomarkers is needed. The most practical seem to be biomarkers that can be obtained easily and minimally invasively. Tape stripping (TS) is a method that provides such an opportunity. This review summarizes the potential biomarkers of AD identified by the minimally invasive TS method. Thymic stromal lymphopoietin (TSLP), interleukin (IL)-13, CC chemokine ligand 17 (CCL17)/thymus and activation-regulated chemokine (TARC) and stratum corneum (SC) lipids can be used as predictive biomarkers for AD occurrence. CCL17/TARC also holds great promise for being reliable biomarkers for AD severity as well as treatment response.Nitric oxide synthase 2 (NOS2)/inducible nitric oxide synthase (iNOS) which high expression is specific for psoriasis may be a good biomarker for differential diagnosis between psoriasis and AD in challenging clinical situations.AD children with food allergy (FA) have a unique endotype characterized by selectively altered expression of various molecules in the skin that can indicate FA coexistence. Unfortunately, although numerous potential biomarkers have been found, none of these candidates have been validated and implemented into routine clinical practice, which still separates us from the possibility of a precise approach to AD patients.
References
Laughter MR, Maymone MBC, Mashayekhi S, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017*. British Journal of Dermatology. 2021;184(2):304-309. doi:10.1111/bjd.19580
Czarnowicki T, He H, Krueger JG, Guttman-Yassky E. Atopic dermatitis endotypes and implications for targeted therapeutics. J Allergy Clin Immunol. 2019;143(1):1-11. doi:10.1016/J.JACI.2018.10.032
Tokura Y, Hayano S. Subtypes of atopic dermatitis: From phenotype to endotype. Allergology International. 2022;71(1):14-24. doi:10.1016/j.alit.2021.07.003
Sroka-Tomaszewska J, Trzeciak M. Molecular Mechanisms of Atopic Dermatitis Pathogenesis. Int J Mol Sci. 2021;22(8). doi:10.3390/IJMS22084130
Mastraftsi S, Vrioni G, Bakakis M, et al. Atopic Dermatitis: Striving for Reliable Biomarkers. J Clin Med. 2022;11(16). doi:10.3390/JCM11164639
Renert-Yuval Y, Thyssen JP, Bissonnette R, et al. Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council. Journal of Allergy and Clinical Immunology. 2021;147(4):1174-1190.e1. doi:10.1016/j.jaci.2021.01.013
Hughes AJ, Tawfik SS, Baruah KP, O’Toole EA, O’Shaughnessy RFL. Tape strips in dermatology research. Br J Dermatol. 2021;185(1):26-35. doi:10.1111/BJD.19760
Keurentjes AJ, Jakasa I, Kezic S. Research Techniques Made Simple: Stratum Corneum Tape Stripping. J Invest Dermatol. 2021;141(5):1129-1133.e1. doi:10.1016/J.JID.2021.01.004
Kim BE, Goleva E, Kim PS, et al. Side-by-Side Comparison of Skin Biopsies and Skin Tape Stripping Highlights Abnormal Stratum Corneum in Atopic Dermatitis. J Invest Dermatol. 2019;139(11):2387-2389.e1. doi:10.1016/J.JID.2019.03.1160
He H, Bissonnette R, Wu J, et al. Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis. Journal of Allergy and Clinical Immunology. 2021;147(1):199-212. doi:10.1016/j.jaci.2020.05.048
Guttman-Yassky E, Diaz A, Pavel AB, et al. Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis. JAMA Dermatol. 2019;155(12):1358. doi:10.1001/jamadermatol.2019.2983
Palmer CNA, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441-446. doi:10.1038/ng1767
Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. Journal of Allergy and Clinical Immunology. 2014;134(4):818-823. doi:10.1016/j.jaci.2014.08.005
Chalmers JR, Haines RH, Bradshaw LE, et al. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial. The Lancet. 2020;395(10228):962-972. doi:10.1016/S0140-6736(19)32984-8
Skjerven HO, Rehbinder EM, Vettukattil R, et al. Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial. The Lancet. 2020;395(10228):951-961. doi:10.1016/S0140-6736(19)32983-6
Kim J, Kim BE, Lee J, et al. Epidermal thymic stromal lymphopoietin predicts the development of atopic dermatitis during infancy. Journal of Allergy and Clinical Immunology. 2016;137(4):1282-1285.e4. doi:10.1016/j.jaci.2015.12.1306
Berdyshev E, Kim J, Kim BE, et al. Stratum corneum lipid and cytokine biomarkers at age 2 months predict the future onset of atopic dermatitis. Journal of Allergy and Clinical Immunology. Published online February 2023. doi:10.1016/j.jaci.2023.02.013
Rinnov MR, Halling A, Gerner T, et al. Skin biomarkers predict development of atopic dermatitis in infancy. Allergy. 2023;78(3):791-802. doi:10.1111/all.15518
Halling AS, Rinnov MR, Ruge IF, et al. Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitis. Journal of Allergy and Clinical Immunology. Published online December 2022. doi:10.1016/j.jaci.2022.11.023
Silvestre Salvador J, Romero-Pérez D, Encabo-Durán B. Atopic Dermatitis in Adults: A Diagnostic Challenge. J Investig Allergol Clin Immunol. 2017;27(2):78-88. doi:10.18176/jiaci.0138
Bieber T, D’Erme AM, Akdis CA, et al. Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go? J Allergy Clin Immunol. 2017;139(4S):S58-S64. doi:10.1016/J.JACI.2017.01.008
Fishbein AB, Silverberg JI, Wilson EJ, Ong PY. Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection. J Allergy Clin Immunol Pract. 2020;8(1):91. doi:10.1016/J.JAIP.2019.06.044
Gargiulo L, Ibba L, Pavia G, et al. Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series. Journal of Dermatological Treatment. 2023;34(1). doi:10.1080/09546634.2023.2183729
McAleer MA, Jakasa I, Hurault G, et al. Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell-related immunity and angiogenesis. Br J Dermatol. 2019;180(3):586-596. doi:10.1111/BJD.17088
Andersson AM, Sølberg J, Koch A, et al. Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsies. Allergy. 2022;77(5):1499-1509. doi:10.1111/all.15153
Lyubchenko T, Collins HK, Goleva E, Leung DYM. Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skin. Annals of Allergy, Asthma & Immunology. 2021;126(1):46-53.e2. doi:10.1016/j.anai.2020.08.397
Amarbayasgalan T, Takahashi H, Dekio I, Morita E. Interleukin-8 content in the stratum corneum as an indicator of the severity of inflammation in the lesions of atopic dermatitis. Int Arch Allergy Immunol. 2013;160(1):63-74. doi:10.1159/000339666
Hulshof L, Hack DP, Hasnoe QCJ, et al. A minimally invasive tool to study immune response and skin barrier in children with atopic dermatitis. British Journal of Dermatology. 2019;180(3):621-630. doi:10.1111/bjd.16994
Clausen ML, Jungersted JM, Andersen PS, Slotved HC, Krogfelt KA, Agner T. Human β-defensin-2 as a marker for disease severity and skin barrier properties in atopic dermatitis. Br J Dermatol. 2013;169(3):587-593. doi:10.1111/BJD.12419
Amarbayasgalan T, Takahashi H, Dekio I, Morita E. Content of vascular endothelial growth factor in stratum corneum well correlates to local severity of acute inflammation in patients with atopic dermatitis. Int Arch Allergy Immunol. 2012;157(3):251-258. doi:10.1159/000327556
Yasuda C, Enomoto A, Ishiwatari S, et al. Macrophage migration inhibitory factor (MIF) in the stratum corneum: a marker of the local severity of atopic dermatitis. Exp Dermatol. 2014;23(10):764-766. doi:10.1111/EXD.12520
Morita E, Takahashi H, Niihara H, et al. Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis. Allergy. 2010;65(9):1166-1172. doi:10.1111/J.1398-9995.2010.02361.X
Sano Y, Masuda K, Tamagawa-Mineoka R, et al. Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis. Clin Exp Immunol. 2013;171(3):330-337. doi:10.1111/cei.12021
Niiyama S, Yoshino T, Yasuda C, et al. Galectin-7 in the stratum corneum: a biomarker of the skin barrier function. Int J Cosmet Sci. 2016;38(5):487-495. doi:10.1111/ics.12326
Goleva E, Calatroni A, LeBeau P, et al. Skin tape proteomics identifies pathways associated with transepidermal water loss and allergen polysensitization in atopic dermatitis. Journal of Allergy and Clinical Immunology. 2020;146(6):1367-1378. doi:10.1016/j.jaci.2020.04.022
Chiba T, Nakahara T, Kohda F, Ichiki T, Manabe M, Furue M. Measurement of trihydroxy-linoleic acids in stratum corneum by tape-stripping: Possible biomarker of barrier function in atopic dermatitis. PLoS One. 2019;14(1). doi:10.1371/JOURNAL.PONE.0210013
Simpson EL, Guttman-Yassky E, Margolis DJ, et al. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis. JAMA Dermatol. 2018;154(8):903. doi:10.1001/jamadermatol.2018.1572
Koppes SA, Brans R, Ljubojevic Hadzavdic S, Frings-Dresen MHW, Rustemeyer T, Kezic S. Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy. Int Arch Allergy Immunol. 2016;170(3):187-193. doi:10.1159/000448400
Murata S, Kaneko S, Morita E. Interleukin-8 Levels in the Stratum Corneum as a Biomarker for Monitoring Therapeutic Effect in Atopic Dermatitis Patients. Int Arch Allergy Immunol. 2021;182(7):592-606. doi:10.1159/000512965
He H, Olesen CM, Pavel AB, et al. Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers. Front Immunol. 2020;11. doi:10.3389/FIMMU.2020.01768
Mikhaylov D, Del Duca E, Olesen CM, et al. Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab. Dermatitis. 2021;32(1S):S71-S80. doi:10.1097/DER.0000000000000764
Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci. 2009;53(1):48-54. doi:10.1016/J.JDERMSCI.2008.08.011
Olesen CM, Pavel AB, Wu J, et al. Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients. J Allergy Clin Immunol Pract. 2021;9(1):576-579.e3. doi:10.1016/j.jaip.2020.08.037
Paller A, Jaworski JC, Simpson EL, et al. Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders. Am J Clin Dermatol. 2018;19(6):821-838. doi:10.1007/s40257-018-0383-4
Leung DYM, Calatroni A, Zaramela LS, et al. The nonlesional skin surface distinguishes atopic dermatitis with food allergy as a unique endotype. Sci Transl Med. 2019;11(480). doi:10.1126/scitranslmed.aav2685
Broderick C, Ziehfreund S, van Bart K, et al. Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review. Allergy. 2023;78(1):84-120. doi:10.1111/all.15578
Ziehfreund S, Tizek L, Hangel N, et al. Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021-a two-round Delphi survey among international experts. J Eur Acad Dermatol Venereol. 2022;36(9):1467-1476. doi:10.1111/JDV.18178
Published
Issue
Section
License
Copyright (c) 2024 Weronika Zysk, Magdalena Trzeciak
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
